HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bail-out intravascular lithotripsy for severe stent underexpansion during primary angioplasty: a case report.

AbstractBACKGROUND:
Intravascular lithotripsy is safe and effective for the treatment of de novo coronary artery calcifications. Its bail-out use in acute coronary syndrome and for underexpanded stents, although currently off-label, could be the best option when other conventional techniques fail.
CASE SUMMARY:
A patient with an inferior ST-segment elevation myocardial infarction underwent a primary percutaneous coronary intervention. Stent underexpansion due to a heavily calcified lesion was refractory to high-pressure balloon dilatations. Complete stent expansion was achieved with intravascular lithotripsy, as evidenced by intravascular ultrasound, and no acute complications occurred.
DISCUSSION:
Treatment strategies for stent underexpansion due to coronary artery calcifications are still debated. High-pressure non-compliant balloon dilatations are rarely sufficient to gain a complete stent expansion. Rotational and orbital atherectomy are contraindicated in presence of a thrombus. Given the possible risks of stent damages, intravascular lithotripsy is currently not indicated in acutely deployed stents but could be the best bail-out technique for otherwise undilatable stents due to severely calcified plaques.
AuthorsNiccolò Ciardetti, Francesca Ristalli, Giulia Nardi, Carlo Di Mario
JournalEuropean heart journal. Case reports (Eur Heart J Case Rep) Vol. 5 Issue 11 Pg. ytab448 (Nov 2021) ISSN: 2514-2119 [Electronic] England
PMID34917883 (Publication Type: Case Reports)
Copyright© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: